AI MODULES FOR CANCER DIAGNOSTICS
Gallery
Overview
Qritive offers a suite of AI-powered diagnostic modules designed to support pathologists across a broad range of clinical applications—from cancer diagnosis and metastasis detection on Hematoxylin and Eosin (H&E) stained whole-slide images (WSI) to biomarker analysis on immunohistochemistry (IHC) WSI.
These modules deliver fast, accurate, and reproducible results by analyzing entire whole-slide images within seconds. Seamlessly integrated into digital pathology workflows, they help reduce interpretation variability, streamline reporting, and support confident decision-making across different tissue types and diagnostic challenges.
Explore our AI module portfolio tailored to meet the needs of modern pathology.
Specifications
| Product / Module | Core Functionality | Key Features & Technology | Clinical Impact |
|---|---|---|---|
| QAi Colon Dx | Colon Cancer Diagnosis | • Identifies benign, dysplastic, and malignant regions • Uses deep learning on digitized biopsies |
• Enhances diagnostic precision • Reduces variability and manual interpretation errors |
| QAi Lymph Node Dx | Metastasis Detection | • Detects macro- and micrometastatic deposits • Directs attention precisely to high-risk areas |
• Improves cancer staging and prognosis • Significantly reduces metastatic screening time |
| IHC Biomarker Quantification | Biomarker Scoring | • Quantifies Ki-67, HER2, and PD-L1 • Supports IHC Whole-Slide Images (WSI) |
• Provides objective scoring for treatment decisions • Aligns results with global clinical guidelines |
Product Brochure
Download detailed specifications & features.
